A New Case of Lethal Congenital Contracture Syndrome Type 3 With Hyperinsulinism and Optic Atrophy
Clinical Genetics · 2026-12 · 110 (6) · 736-741
DOI: 10.1111/cge.70231 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Genetics, online erschienen am 16.09.2026. Verfasst von Tameemi Abdalla Moady und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. Hauptthemen laut MEDLINE: Arthrogryposis, Contracture, Hyperinsulinism, Optic Atrophy. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kontrakturprophylaxe
Abstract (Originalsprache)
Lethal congenital contracture syndrome 3 (LCCS3, MIM #611369) is a rare autosomal recessive neuromuscular disorder caused by biallelic loss‐of‐function (LOF) variants in PIP5K1C , reported in only two families to date. It typically presents with severe fetal akinesia, arthrogryposis multiplex congenita, and perinatal lethality due to respiratory insufficiency case. Herein, we report a new case with survival beyond birth. Prenatal findings included clubfeet with preserved amniotic fluid volume and fetal movements. The infant was delivered by cesarean section at 37 + 7 weeks following breech presentation and developed respiratory distress requiring 14 days of ventilatory support. Physical examination revealed bilateral talipes equinovarus, flexion contractures of the knees, restricted hip mobility, clenched hands with flexion contractures of the third and fourth fingers, and hyperextension of the second and fifth fingers. Neurologically, he had encephalopathy, profound hypotonia with a frog posture, and abnormal neonatal reflexes with a discontinuous background pattern on cerebral function monitoring. Additional observed features were bilateral optic atrophy and hyperinsulinemic hypoglycemia responsive to Diazoxide. Trio genome sequencing identified a homozygous pathogenic splice‐site variant in PIP5K1C (c.1127+1G>A, NM_012398.3). The infant died at 6 months from multisystemic failure. Further studies are warranted to elucidate the pathomechanisms underlying the PIP5K1C defect and its phenotypic consequences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
- Genetics Institute, Rambam Health Care Center, Haifa, Israel.
- The Hebrew University of Jerusalem, Jerusalem, Israel.
- Pediatric Endocrinology and Diabetes Unit, Rambam Health Care Center, Haifa, Israel.
ORCID-Profile: Tameemi Abdalla Moady, Michal Cohen, Karin Weiss
Zitieren
APA
Abdalla Moady, T., Ma'ayan, H. H., Cohen, M., & Weiss, K. (2026). A New Case of Lethal Congenital Contracture Syndrome Type 3 With Hyperinsulinism and Optic Atrophy. Clinical Genetics, 110(6), 736-741. https://doi.org/10.1111/cge.70231
Vancouver
Abdalla Moady T, Ma'ayan HH, Cohen M, Weiss K. A New Case of Lethal Congenital Contracture Syndrome Type 3 With Hyperinsulinism and Optic Atrophy. Clinical Genetics. 2026;110(6):736-741. doi:10.1111/cge.70231
BibTeX
@article{AbdallaMoady2026,
author = {Abdalla Moady, Tameemi and Ma'ayan, Hadar Hulin and Cohen, Michal and Weiss, Karin},
title = {A New Case of Lethal Congenital Contracture Syndrome Type 3 With Hyperinsulinism and Optic Atrophy},
journal = {Clinical Genetics},
year = {2026},
volume = {110},
number = {6},
pages = {736--741},
doi = {10.1111/cge.70231}
}
EUVIMED